Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey.
Harkins RA, Patel SP, Lee MJ, Switchenko JM, Ansell SM, Bartlett NL, Blum KA, Cashen AF, Casulo C, Friedberg JW, Johnston PB, Kahl BS, Leonard JP, Link BK, Lossos IS, Martin P, Maurer MJ, Mehta-Shah N, Reagan PM, Westin JR, Koff JL, Flowers CR. Harkins RA, et al. Among authors: maurer mj. Blood Adv. 2022 May 10;6(9):2745-2756. doi: 10.1182/bloodadvances.2021006504. Blood Adv. 2022. PMID: 35100356 Free PMC article.
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
Micallef IN, Kahl BS, Maurer MJ, Dogan A, Ansell SM, Colgan JP, Geyer S, Inwards DJ, White WL, Habermann TM. Micallef IN, et al. Among authors: maurer mj. Cancer. 2006 Dec 15;107(12):2826-32. doi: 10.1002/cncr.22342. Cancer. 2006. PMID: 17099879 Free article. Clinical Trial.
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P. Cerhan JR, et al. Among authors: maurer mj. Blood. 2007 Jun 15;109(12):5439-46. doi: 10.1182/blood-2006-11-058040. Epub 2007 Feb 27. Blood. 2007. PMID: 17327408 Free PMC article.
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, Ansell SM, Hartge P, Severson RK, Rothman N, Davis S, Geyer SM, Cozen W, Chanock SJ, Cerhan JR. Habermann TM, et al. Among authors: maurer mj. Blood. 2008 Oct 1;112(7):2694-702. doi: 10.1182/blood-2007-09-111658. Epub 2008 Jul 16. Blood. 2008. PMID: 18633131 Free PMC article.
227 results